FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Galantamine Hydrobromide Tablets
Status: Discontinuation
»Therapeutic Categories: Neurology

Expand all

Janssen Pharmaceuticals (New 10/29/2018)

Company Contact Information:
800-526-7736

Presentation Posting Date Related Information
4 mg tablets (NDCs 50458-396-60 and 10147-0881-6) 10/29/2018 The last batches will be distributed April 2019.
8 mg tablets (NDCs 50458-397-60 and 10147-0882-6) 10/29/2018 The last batches will be distributed April 2019.
12 mg tablets (NDCs 50458-398-60 and 10147-0883-6) 10/29/2018 The last batches will be distributed April 2019.

Mylan Pharmaceuticals Inc. (New 06/19/2018)

Company Contact Information:
800-RXMYLAN (1-800-496-9526)

Presentation Posting Date Related Information
4 mg, 60 count bottle (NDC 0378-2721-91) 06/19/2018 The discontinuation of this product is a business decision.
8 mg, 60 count bottle (NDC 0378-2722-91) 06/19/2018 The discontinuation of this product is a business decision.
12 mg, 60 count bottle (NDC 0378-2723-91) 06/19/2018 The discontinuation of this product is a business decision.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English